{'fraction_non_alphanumeric': 0.048701298701298704, 'fraction_numerical': 0.0016233766233766235, 'mean_word_length': 6.174418604651163, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effect of PET‐CT on disease recurrence and management in patients with potentially resectable colorectal cancer liver metastases. Long‐term results of a randomized controlled trial

Preoperative evaluation of resectable colorectal cancer liver metastases with positron emission tomography (PET) combined with computed tomography (PET‐CT) is used extensively. The PETCAM trial evaluated the effect of PET‐CT (intervention) vs no PET‐CT (control) on surgical management. PET‐CT resulted in 8% change in surgical management, therefore, we aimed to compare long‐term outcomes (disease‐free [DFS], overall survival [OS]).